Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson’s Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque
Keyword(s):
2019 ◽
Vol 311
◽
pp. 277-287
◽
Keyword(s):
2013 ◽
Vol 3
(3)
◽
pp. 275-291
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 231
(2)
◽
pp. 309-313
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 336
(2)
◽
pp. 423-430
◽
Keyword(s):